Share Buyback Transaction Details February 27 – March 5, 2025

Seeking Alpha / 36 minutes from now 1 Views

PRESS RELEASE

CERo Therapeutics Holdings, Inc. Announces Progress in Initiation of Phase 1 Clinical Trial by Executing an Agreement with Contract Research Organization CellCarta to Manage Translational Assays

4 hours from now
No. 7/2025 - Managers’ transactions

4 hours from now
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds

4 hours from now
Nr. 7/2025 - Ledende medarbejderes transaktioner

4 hours from now
Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises

4 hours from now